A healthier world made possible by supersizing the potential of powerful particles

Watch now

Interdisciplinary research

Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health.

Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.

Collaboration across the United States

The Nanovaccine Institute is a consortium of researchers at universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University.

Revolutionizing how we
6 6
Focus Areas
87 87
Researchers
27 27
Institutions
prevent and treat disease